Abstract
The incidence of breast cancer in India is on the rise and is rapidly becoming the number one cancer in females pushing the cervical cancer to the second position. The mutations in two breast cancer susceptibility genes, BRCA1 and BRCA2, are frequently associated with familial breast cancer. The main objective of the study was to determine the frequency of the mutation 5382insC in BRCA1 of eastern Indian breast cancer patients and also study the hormonal receptor status and histopathology of the patients. Altogether 92 patients affected with breast cancer were included in this study. ARMS-PCR based amplification was used to detect the presence of mutation. The mutations were considered only after pedigree analysis. Out of 92 patients (age range: 20–77 years) with family history (57 individuals) and without family history (35 individuals) were screened. Fifty controls have been systematically investigated. Seven patients and two family members were found to be carriers of 5382insC mutation in BRCA1 gene. We have found 42.64 % ER−/PR− cancer and 20.58 % triple negative cancer. Invasive ductal carcinoma is the most common histology among the investigated individuals. The presented data confirm a noticeable contribution of BRCA1 5382insC mutation in BC development in Eastern India, which may justify an extended BRCA1 5382insC testing within this patient population. We found HER-2/neu negativity and BRCA1 positivity associated with familial breast cancer. From the hospital’s patient history, it was revealed that the age of menarche plays an important role in development of breast cancer.
Similar content being viewed by others
Abbreviations
- BC:
-
Breast cancer
- OC:
-
Ovarian cancer
- ER:
-
Estrogen receptor
- PR:
-
Progesterone receptor
- TNBC:
-
Triple negative breast cancer
- HER2:
-
Human epidermal growth factor receptor 2
- PTEN:
-
Phosphate and tensin homolog
- ICMR:
-
Indian Council of Medical Research
- PBCR:
-
Population based cancer registry
- BRCA1:
-
Breast cancer gene one
- BRCA2:
-
Breast cancer gene two
- ATM:
-
Ataxia telangiectasia mutated gene
- p53:
-
Tumor protein 53
- ARMS-PCR:
-
Amplification refractory mutation system-polymerase chain reaction
References
Gad S, Caux-Moncoutier V, Pagès-Berhouet S et al (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21(44):6841–6847
Lux MP, Fasching PA, Beckmann MW (2006) Hereditary breast cancer and ovarian cancer: review and future perspectives. J Mol Med 84:16–28
Saxena S, Chakraborty A, Kaushal M et al (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 4:75–87
Dinshaw KA, Sarin R, Budrukkar AN et al (2006) Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital. J Surg Oncol 94:105–113
Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040
Hall JM, Lee M-K, Newman B et al (1990) Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 250:1684–1689
Narod SA, Feunteun J, Lynch HT et al (1991) Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet 338:82–83
Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71
Futreal PA, Liu Q, Shattuck-Eidens D et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122
Newman B, Austin MA, Lee M, King M-C (1988) Inheritance of breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 85:1–5
Castilla LH, Couch FJ, Erdos MR et al (1994) Mutations in the BRCA1 gene in families with early onset breast and ovarian cancer. Nat Genet 8:387–391
Friedman LS, Ostermeyer EA, Szabo CI et al (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399–404
Neuhausen SL, Mazoyer S, Friedman L et al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271–280
Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265:2088–2090
Ford D, Easton DE, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1 mutation carriers. Breast cancer linkage consortium. Lancet 343:692–695
Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408
Gayther S, Mangion J, Russel P et al (1997) Variation of risk of breast and ovarian cancer associated with different germ-line mutations of the BRCA2 gene. Nat Genet 58:103–105
Ramus SJ, Kote-Jarai Z, Friedman LS et al (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60:1242–1246
Simard J, Tonin P, Durocher F et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392–398
Backe J, Hofferbert S, Skawran B et al (1999) Frequency of BRCA1 mutation 5382insC German breast cancer patients. Gynecol Oncol 72:402–406
Vehmanen P, Friedman LS, Eerola H et al (1997) Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 6:2309–2315
Johannsson O, Ostermmeyer EA, Hakansson S et al (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 58:441–450
Hakansson S, Johannsson O, Johansson U et al (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60:1068–1078
Andersen TI, Borresen AL, Moller PA (1996) A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 59:486–487
Deapen D, Liu L, Perkins C, Bernstein L, Ross RK (2002) Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 99(5):747–750
Lee SY, Jeong SH, Kim YN et al (2009) Cost effective mammography screening in Korea: high incidence of breast cancer in young women. Cancer Sci 100(6):1105–1111
Adebamowo CA, Famooto A, Ogundiran TO et al (2008) Immuno histochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183–188
Lin CH, Liau JY, Lu YS et al (2009) Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev 18(6):1807–1814
Nichols HB, Trentham-Dietz A, Love RR et al (2005) Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev 14(1):41–47
Miller SS, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Chan PC, Wong BY, Ozcelik H, Cole DE (1999) Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clin Chem 45:1285–1287
Pearson PL, Van der Luijt RB (1998) The genetic analysis of cancer. J Intern Med 243(6):413–417
Melbye M, Wohlfahrt J, Olsen JH et al (1997) Induced abortion and the risk of breast cancer. N Engl J Med 336:81–85
Wang QS, Ross PK, Yu MC et al (1992) A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev 1:435–439
Rosner B, Colditz GA (1996) Nurses’ Health Study: log incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 88:359–364
Bouchardy C, Le MG, Hill C (1990) Risk factors for breast cancer according to age at diagnosis in a French case control study. J Clin Epidiol 43:267–274
Rilke F, Di Palma S (1998) Pathology. In: Bonadonna G, Hortobagyi GN, Gianni AM (eds) Text book of breast cancer. A clinical guide to therapy, 1st edn. Martin Dunitz Ltd, London, pp 2–3
Newcomb P, Storer B, Longnecker M et al (1994) Lactation and a reduced risk premenopausal breast cancer. N Engl J Med 330:81–87
Lahad EL, Catane R, Eisenberg S et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jewish: frequency and differential penetrance in ovarian cancer and in breast/ovarian cancer families. Am J Hum Genet 60:1059–1067
Acknowledgments
We owe our sincere acknowledgement to the patients and their family members for their extensive cooperation with us and participating in the study. We are also grateful to Ms Nabamita Pal, Mr. Raghabendra Mishra, Swati Dasgupta, Priyabrata Das and Mr. Kunal Chakraborty for their valuable contribution. We also thank all the staffs in the hospital who have helped to accomplish the study successfully.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chakraborty, A., Mukhopadhyay, A., Bhattacharyya, D. et al. Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. Familial Cancer 12, 489–495 (2013). https://doi.org/10.1007/s10689-012-9590-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-012-9590-y